These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Similar long-term results of breast-conservation treatment for Stage I and II invasive lobular carcinoma compared with invasive ductal carcinoma of the breast: The University of Pennsylvania experience. Santiago RJ, Harris EE, Qin L, Hwang WT, Solin LJ. Cancer; 2005 Jun 15; 103(12):2447-54. PubMed ID: 15887223 [Abstract] [Full Text] [Related]
5. Long-term cosmesis after lumpectomy and brachytherapy in the management of carcinoma of the previously irradiated breast. Trombetta M, Julian TB, Werts DE, McWilliams W, Kim Y, Miften M, Parda D. Am J Clin Oncol; 2009 Jun 15; 32(3):314-8. PubMed ID: 19451803 [Abstract] [Full Text] [Related]
7. NCCN: Breast cancer. Carlson RW, Edge SB, Theriault RL, NCCN Breast Cancer Practice Guidelines Panel. Cancer Control; 2001 Jun 15; 8(6 Suppl 2):54-61. PubMed ID: 11760559 [Abstract] [Full Text] [Related]
8. Bilateral synchronous breast carcinomas followed by a metastasis to the gallbladder: a case report. Zagouri F, Sergentanis TN, Koulocheri D, Nonni A, Bousiotou A, Domeyer P, Michalopoulos NV, Dardamanis D, Konstadoulakis MM, Zografos GC. World J Surg Oncol; 2007 Sep 11; 5():101. PubMed ID: 17848197 [Abstract] [Full Text] [Related]
9. Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system. Hudis CA, Barlow WE, Costantino JP, Gray RJ, Pritchard KI, Chapman JA, Sparano JA, Hunsberger S, Enos RA, Gelber RD, Zujewski JA. J Clin Oncol; 2007 May 20; 25(15):2127-32. PubMed ID: 17513820 [Abstract] [Full Text] [Related]
10. Is pleomorphic lobular carcinoma really a distinct clinical entity? Buchanan CL, Flynn LW, Murray MP, Darvishian F, Cranor ML, Fey JV, King TA, Tan LK, Sclafani LM. J Surg Oncol; 2008 Oct 01; 98(5):314-7. PubMed ID: 18668643 [Abstract] [Full Text] [Related]
11. Invasive breast cancer. Carlson RW, Anderson BO, Burstein HJ, Carter WB, Edge SB, Farrar WB, Goldstein LJ, Gradishar WJ, Hayes DF, Hudis CA, Jahanzeb M, Ljung BM, Kiel K, Marks LB, McCormick B, Nabell LM, Pierce LJ, Reed EC, Silver SM, Smith ML, Somlo G, Theriault RL, Ward JH, Winer EP, Wolff AC. J Natl Compr Canc Netw; 2007 Mar 01; 5(3):246-312. PubMed ID: 17439758 [No Abstract] [Full Text] [Related]
12. Tailoring therapies--improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015. Coates AS, Winer EP, Goldhirsch A, Gelber RD, Gnant M, Piccart-Gebhart M, Thürlimann B, Senn HJ, Panel Members. Ann Oncol; 2015 Aug 01; 26(8):1533-46. PubMed ID: 25939896 [Abstract] [Full Text] [Related]
15. Tubular carcinoma of the breast: institutional and SEER database analysis supporting a unique classification. Romano AM, Wages NA, Smolkin M, Fortune KL, Atkins K, Dillon PM. Breast Dis; 2015 Aug 01; 35(2):103-11. PubMed ID: 25567000 [Abstract] [Full Text] [Related]
19. [Breast cancer treatment]. Duodecim; 2005 Aug 01; 121(3):317-8. PubMed ID: 15787290 [No Abstract] [Full Text] [Related]
20. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001. Li CI, Malone KE, Saltzman BS, Daling JR. Cancer; 2006 May 15; 106(10):2104-12. PubMed ID: 16604564 [Abstract] [Full Text] [Related] Page: [Next] [New Search]